REGULATED PRESS RELEASE published on 04/26/2024 at 07:28, 2 years 6 months ago Aéroports de Paris SA - 2024 1st quarter revenue
PRESS RELEASE published on 04/26/2024 at 07:24, 2 years 6 months ago EQS-Adhoc: thyssenkrupp AG: thyssenkrupp and EP Corporate Group enter into strategic partnership thyssenkrupp AG and EP Corporate Group enter into strategic partnership, with EPCG acquiring 20% stake in thyssenkrupp's steel business, aiming for 50/50 joint venture Acquisition Strategic Partnership ThyssenKrupp AG EP Corporate Group Steel Business
PRESS RELEASE published on 04/26/2024 at 07:20, 2 years 6 months ago EQS-Adhoc: ams-OSRAM AG: delivers solid Q1 revenues of EUR 847m, adj. EBIT margin of 5.2%, restructures microLED development, works on exiting 8-inch fab SLB, on track for positive FCF (after interest) in 2025 ams-OSRAM AG delivers solid Q1 revenues of EUR 847m, adj. EBIT margin of 5.2%, restructures microLED development, works on exiting 8-inch fab SLB, on track for positive FCF in 2025 Restructuring MicroLED Ams-OSRAM AG Q1 Revenues Positive FCF
PRESS RELEASE published on 04/26/2024 at 07:01, 2 years 6 months ago PALFINGER AG: Outstanding results for PALFINGER AG in the first quarter PALFINGER AG reported outstanding results in Q1 2024 with EUR 578.5 million revenue, record EBIT of EUR 54.7 million and consolidated net result of EUR 32.5 million despite economic challenges. Positive developments in North America, Asia, and the Marine Sector Revenue North America EBIT PALFINGER AG Q1 2024 Results
PRESS RELEASE published on 04/26/2024 at 07:00, 2 years 6 months ago Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed Curatis Holding AG announces completion of business combination with Curatis AG, trading on SIX Swiss Exchange under CURN.SW. Specializes in orphan drugs with risk-balanced model Business Combination SIX Swiss Exchange Curatis Holding AG Orphan Drugs Specialty Pharmaceuticals
PRESS RELEASE published on 04/26/2024 at 07:00, 2 years 6 months ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first quarter of 2024, revealing a net profit of CHF 260 million. The report includes details on the company's investment activities and performance Investment Company Net Profit BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/26/2024 at 07:00, 2 years 6 months ago BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates BB Biotech reports solid first-quarter results as interest rates impact biotech stock market. Net profit reaches CHF 260 mn. Key portfolio adjustments and milestones highlighted Interest Rates First-quarter Results BB Biotech Biotech Stock Market Portfolio Adjustments
PRESS RELEASE published on 04/26/2024 at 07:00, 2 years 6 months ago Branicks Group expands business model to include renewables asset class and cooperates with Encavis Asset Management AG Branicks Group AG expands business model to include renewables asset class through cooperation with Encavis Asset Management AG, focusing on sustainable investments and ESG criteria Branicks Group AG Sustainable Investments Encavis Asset Management AG Renewables Asset Class ESG Criteria
REGULATED PRESS RELEASE published on 04/26/2024 at 07:00, 2 years 6 months ago Safran - Solid momentum continues: guidance confirmed Safran reports 18.1% revenue growth in Q1 2024, with solid momentum across all businesses. Full-year 2024 guidance confirmed by CEO Olivier Andriès. Currency hedges and share repurchase programs outlined Safran Revenue Growth CEO Q1 2024 Currency Hedges
PRESS RELEASE published on 04/26/2024 at 06:55, 2 years 6 months ago STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2024 STRATEC SE reports first quarter 2024 results with consolidated sales down 15.7% at constant currency to € 50.9 million. Adjusted EBIT margin almost stable at 6.2%. Financial guidance for 2024 confirmed with expected sales growth Financial Guidance Sales Growth First Quarter Results Adjusted EBIT Margin STRATEC SE
Published on 11/06/2026 at 22:15, 1 day 14 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/08/2026 at 12:10, 51 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 2 hours 46 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 23 hours 26 minutes ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 1 day 16 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 1 day 17 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 17:54, 1 day 19 hours ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 1 day 19 hours ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026